1) Compatibility with both Dexcom G6 and G7
2) Duration timer for Exercise Activity (customizable from 30 mins to 8 hours)
3) Six-digit numeric Mobile App pairing code (previously 16 alpha-numeric)
4) Updated pump sounds
5) Seamless Activity transition (no need to stop an Activity before switching to a different Activity)
6) Updated Auto-Off alarm defaulted off (with new pumps) 

Dexcom and Tandem have been trusted partners in diabetes management for over 10 years. Dexcom G7 and Tandem t:slim X2 insulin pump key differentiators include:

>Short - 30 minute warmup
>Ability to use Share and Follow features to share your numbers with up to 10 people
>Non-adjunctive, meaning no fingersticks to make treatment decisions

For existing t:slim X2 with Control-IQ users, there is no pump prescription needed to update the pump software. 

If your patient received an incompatible Dexcom G7 sensor, please visit https://www.tandemdiabetes.com/support/compatibility/dexcom-cgm. 

You will learn how to identify a compatible Dexcom G7 sensor on:
- Pump screen error message
- Tandem training checklist for new users
- Software update portal for current users

For additional information, please navigate to https://www.tandemdiabetes.com/support/compatibility/dexcom-cgm

Rebecca is a 67-year-old female who was diagnosed with T2D 12 years ago.

Current treatment: Metformin 1000 mg BID, Sitagliptin 100 mg QD, Glimepiride 4 mg BID, basal insulin (glargine) 36 units QPM Current A1C: 9.8%

Rebecca is motivated to manage diabetes but struggles with eating lower carbohydrate foods consistently. She’s busy with volunteering activities and her new post-retirement social life. When Rebecca was working, she kept her blood glucose meter at her desk and would check her glucose 1-3 times daily. Nowadays, she often forgets to bring the meter with her when she’s out and about.

Rebecca’s primary care provider (PCP) recognizes her desire to better manage her diabetes and wants to provide a tool that shows her glucose patterns and trends. Her PCP believes Rebecca can use that information to adjust her medications and improve overall glycemic management. In addition, expanded Medicare coverage criteria* includes anyone with diabetes treated with any type of insulin.

Glucose patterns and trends shown on Dexcom Clarity reports allowed Rebecca’s PCP to see what areas to improve and made medication adjustments to address her persistent evening and overnight hyperglycemia.# Her new medication plan included changing glimepiride to dapagliflozin (SGLT-2i), changing sitagliptin to semaglutide (GLP-1 RA) 0.25 mg titrated up to 1 mg weekly, continue on Dexcom G7, and follow up in 3 months.

At 3-month office visit, Rebecca’s A1C had decreased to 7.2% with improved postprandial hyperglycemia. Her Dexcom Clarity reports showed overnight hypoglycemia and glycemic variability. Her PCP recommended reducing her basal insulin to 18 units QPM and continuing with lifestyle modifications. Rebecca is now using Dexcom G7 to guide meal choices and thanks to Dexcom G7 alerts, she can intervene earlier to prevent or minimize hypoglycemia episodes.

Steve, a 68-year-old male who is very active. Despite being prescribed basal and mealtime insulin, he doesn’t take it due to fear of hypoglycemia.

Current treatment: Metformin, basal insulin (degludec), and meal-time insulin (lispro)

Current A1C: 8.9%